Form 4 filed by Bazemore Robert B
Bazemore Robert B filed this Form 4 on AKTX (Akari Therapeutics Plc) with 8 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-16 21:20:11 UTC.
- Accession
- 0001493152-26-047455
- Filer
- CIK 1620152
- Filed
- 2026-10-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: AKTX · Akari Therapeutics Plc (CIK 1541157)
- Bazemore Robert B director
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares | 2026-08-18 | A granted | +13,100 | $7.899 | 14,216 | D |
| American Depositary Shares representing Ordinary Shares | 2026-10-05 | A granted | +4,677 | $7.899 | 18,893 | D |
| American Depositary Shares representing Ordinary Shares | 2026-10-14 | M exercised | +773 | $0.0004 | 19,666 | D |
| American Depositary Shares representing Ordinary Shares | 2026-10-14 | M exercised | +3,093 | $0.0004 | 22,759 | D |
| Stock Option (Right to Buy) derivative | 2026-08-18 | A granted | +45,000 | $0 | 45,000 | D |
| Stock Option (Right to Buy) derivative | 2026-08-18 | A granted | +15,000 | $0 | 15,000 | D |
| Pre-Funded Warrant to Purchase ADSs derivative | 2026-10-14 | M exercised | -773 | $16.16 | 0 | D |
| Pre-Funded Warrant to Purchase ADSs derivative | 2026-10-14 | M exercised | -3,093 | $16.16 | 0 | D |